Spire Healthcare Group (SPI) Upgraded to “Buy” by Jefferies Group

Jefferies Group upgraded shares of Spire Healthcare Group (LON:SPI) to a buy rating in a research report released on Wednesday morning. Jefferies Group currently has GBX 290 ($3.93) price target on the stock, up from their previous price target of GBX 259 ($3.51).

A number of other analysts have also commented on SPI. Numis Securities reaffirmed an add rating and set a GBX 296 ($4.01) price objective on shares of Spire Healthcare Group in a research note on Tuesday. JPMorgan Chase & Co. reaffirmed a neutral rating and set a GBX 339 ($4.60) price objective on shares of Spire Healthcare Group in a research note on Thursday, January 4th. Liberum Capital reaffirmed a hold rating and set a GBX 270 ($3.66) price objective on shares of Spire Healthcare Group in a research note on Tuesday. Finally, Berenberg Bank reaffirmed a hold rating and set a GBX 270 ($3.66) price objective on shares of Spire Healthcare Group in a research note on Thursday, September 21st. One analyst has rated the stock with a sell rating, four have issued a hold rating and two have given a buy rating to the stock. The company presently has a consensus rating of Hold and an average price target of GBX 309.17 ($4.19).

Spire Healthcare Group (LON SPI) traded up GBX 3.80 ($0.05) during mid-day trading on Wednesday, reaching GBX 253.80 ($3.44). 703,989 shares of the company’s stock were exchanged, compared to its average volume of 1,280,000. Spire Healthcare Group has a 52 week low of GBX 218.20 ($2.96) and a 52 week high of GBX 362.10 ($4.91). The stock has a market capitalization of $1,020.00 and a price-to-earnings ratio of 3,625.71.

In related news, insider Justin Ash purchased 84,500 shares of Spire Healthcare Group stock in a transaction dated Thursday, November 23rd. The stock was acquired at an average cost of GBX 237 ($3.21) per share, with a total value of £200,265 ($271,582.59). Also, insider Peter R. Bamford purchased 5,000 shares of Spire Healthcare Group stock in a transaction dated Monday, November 27th. The stock was bought at an average cost of GBX 240 ($3.25) per share, with a total value of £12,000 ($16,273.39).

ILLEGAL ACTIVITY WARNING: This piece of content was originally published by Community Financial News and is owned by of Community Financial News. If you are viewing this piece of content on another publication, it was copied illegally and reposted in violation of US and international trademark & copyright legislation. The legal version of this piece of content can be viewed at https://www.com-unik.info/2018/01/18/spire-healthcare-group-spi-upgraded-to-buy-by-jefferies-group.html.

About Spire Healthcare Group

Spire Healthcare Group plc is a United Kingdom-based independent hospital group. The Company provides in-patient, daycase and out-patient care from approximately 40 hospitals, 10 clinics and over two specialist care centers across the United Kingdom. The Company also owns and operates a sports medicine, physiotherapy and rehabilitation brand, Perform, and a screening service, Lifescan, as well as national pathology services.

Analyst Recommendations for Spire Healthcare Group (LON:SPI)

Receive News & Ratings for Spire Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit